← FDA Drug Approvals (Drugs@FDA)
SEVELAMER CARBONATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: IMPAX · Approved 2020-11-20
Drug application
- FDA Application #
ANDA211316- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- SEVELAMER CARBONATE
- Generic name
- SEVELAMER CARBONATE
- Active ingredients
- SEVELAMER CARBONATE
- Dosage form
- FOR SUSPENSION
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- IMPAX
- Manufacturer
- Amneal Pharmaceuticals of New York LLC
- First approval
- 2020-11-20
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown